0001140361-21-017530.txt : 20210514 0001140361-21-017530.hdr.sgml : 20210514 20210514215609 ACCESSION NUMBER: 0001140361-21-017530 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20210512 FILED AS OF DATE: 20210514 DATE AS OF CHANGE: 20210514 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ABBRECHT TODD M CENTRAL INDEX KEY: 0001260937 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36730 FILM NUMBER: 21927184 MAIL ADDRESS: STREET 1: C/O THOMAS H. LEE PARTNERS, L.P. STREET 2: 100 FEDERAL STREET, 35TH FLOOR CITY: BOSTON STATE: MA ZIP: 02110 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: THOMAS H. LEE ADVISORS, LLC CENTRAL INDEX KEY: 0001260943 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36730 FILM NUMBER: 21927188 BUSINESS ADDRESS: STREET 1: C/O THOMAS H. LEE PARTNERS, L.P. STREET 2: 100 FEDERAL STREET, 35TH FLOOR CITY: BOSTON STATE: MA ZIP: 02110 BUSINESS PHONE: 6172271050 MAIL ADDRESS: STREET 1: C/O THOMAS H. LEE PARTNERS, L.P. STREET 2: 100 FEDERAL STREET, 35TH FLOOR CITY: BOSTON STATE: MA ZIP: 02110 FORMER NAME: FORMER CONFORMED NAME: LEE THOMAS H ADVISORS LLC DATE OF NAME CHANGE: 20030822 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Nelson Joshua M CENTRAL INDEX KEY: 0001375529 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36730 FILM NUMBER: 21927183 MAIL ADDRESS: STREET 1: 100 FEDERAL STREET STREET 2: FLOOR 35 CITY: BOSTON STATE: MA ZIP: 02110 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: THL Fund VII Coinvestment Partners, L.P. CENTRAL INDEX KEY: 0001713702 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36730 FILM NUMBER: 21927187 BUSINESS ADDRESS: STREET 1: C/O THOMAS H LEE PARTNERS, L.P. STREET 2: 100 FEDERAL STREET, 35TH FLOOR CITY: BOSTON STATE: MA ZIP: 02110 BUSINESS PHONE: 617-227-1050 MAIL ADDRESS: STREET 1: C/O THOMAS H LEE PARTNERS, L.P. STREET 2: 100 FEDERAL STREET, 35TH FLOOR CITY: BOSTON STATE: MA ZIP: 02110 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: THL Executive Fund VII, L.P. CENTRAL INDEX KEY: 0001665668 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36730 FILM NUMBER: 21927186 BUSINESS ADDRESS: STREET 1: C/O THOMAS H. LEE PARTNERS, L.P. STREET 2: 100 FEDERAL STREET CITY: BOSTON STATE: MA ZIP: 02110 BUSINESS PHONE: 617-227-1050 MAIL ADDRESS: STREET 1: C/O THOMAS H. LEE PARTNERS, L.P. STREET 2: 100 FEDERAL STREET CITY: BOSTON STATE: MA ZIP: 02110 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: THL Equity Fund VII Investors (inVentiv), L.P. CENTRAL INDEX KEY: 0001713160 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36730 FILM NUMBER: 21927185 BUSINESS ADDRESS: STREET 1: C/O THOMAS H LEE PARTNERS, L.P. STREET 2: 100 FEDERAL STREET, 35TH FLOOR CITY: BOSTON STATE: MA ZIP: 02110 BUSINESS PHONE: 617-227-1050 MAIL ADDRESS: STREET 1: C/O THOMAS H LEE PARTNERS, L.P. STREET 2: 100 FEDERAL STREET, 35TH FLOOR CITY: BOSTON STATE: MA ZIP: 02110 FORMER NAME: FORMER CONFORMED NAME: Thomas H. Lee Equity Fund VII Investors (inVentiv), L.P. DATE OF NAME CHANGE: 20170726 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Syneos Health, Inc. CENTRAL INDEX KEY: 0001610950 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 273403111 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1030 SYNC STREET CITY: MORRISVILLE STATE: NC ZIP: 27560 BUSINESS PHONE: 919-876-9300 MAIL ADDRESS: STREET 1: 1030 SYNC STREET CITY: MORRISVILLE STATE: NC ZIP: 27560 FORMER COMPANY: FORMER CONFORMED NAME: INC Research Holdings, Inc. DATE OF NAME CHANGE: 20140616 4 1 form4.xml FORM 4 X0306 4 2021-05-12 0001610950 Syneos Health, Inc. SYNH 0001260943 THOMAS H. LEE ADVISORS, LLC C/O THOMAS H. LEE PARTNERS, L.P. 100 FEDERAL STREET, 35TH FLOOR BOSTON MA 02110 true 0001713702 THL Fund VII Coinvestment Partners, L.P. C/O THOMAS H. LEE PARTNERS, L.P. 100 FEDERAL STREET, 35TH FLOOR BOSTON MA 02110 true 0001665668 THL Executive Fund VII, L.P. C/O THOMAS H. LEE PARTNERS, L.P. 100 FEDERAL STREET, 35TH FLOOR BOSTON MA 02110 true 0001713160 THL Equity Fund VII Investors (inVentiv), L.P. C/O THOMAS H. LEE PARTNERS, L.P. 100 FEDERAL STREET, 35TH FLOOR BOSTON MA 02110 true 0001260937 ABBRECHT TODD M C/O THOMAS H. LEE PARTNERS, L.P. 100 FEDERAL STREET, 35TH FLOOR BOSTON MA 02110 true 0001375529 Nelson Joshua M C/O THOMAS H. LEE PARTNERS, L.P. 100 FEDERAL STREET, 35TH FLOOR BOSTON MA 02110 true Class A Common Stock 5601430 I See footnote Class A Common Stock 916 D Class A Common Stock 352 D Class A Common Stock 2021-05-12 4 A 0 2364 A 13392 D Class A Common Stock 2021-05-12 4 A 0 2364 A 13392 D See Exhibit 99.1 for text of footnote (1). See Exhibit 99.1 for text of footnote (2). See Exhibit 99.1 for text of footnote (3). See Exhibit 99.1 for text of footnote (4). See Exhibit 99.1 for text of footnote (5). See Exhibit 99.1 for text of footnote (6). See Exhibit 99.1 for text of footnote (7). See Exhibit 99.1 for text of footnote (8). See Exhibit 99.1 for text of footnote (9). Exhibit 99.1 (Form 4 Footnotes) and Exhibit 99.2 (Joint Filer Information) are incorporated herein by reference. This Form 4 is the second of two Forms 4 being filed relating to the same event. The Form 4 has been split into two filings because there are more than 10 Reporting Persons in total, and the SEC's EDGAR filing system limits a single Form 4 to a maximum of 10 Reporting Persons. Each Form 4 will be filed by Designated Filer Thomas H. Lee Advisors, LLC. ** See Exhibit 99.2 for Signatures 2021-05-14 EX-99.1 2 brhc10024660_ex99-1.htm EXHIBIT 99.1
Exhibit 99.1

Name and Address of Reporting Person:
Thomas H. Lee Advisors, LLC

c/o Thomas H. Lee Partners, L.P.

100 Federal Street, 35th Floor

Boston, MA 02210
   
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]
   
Date of Earliest Transaction Required to
  
be Reported (Month/Day/Year):
May 12, 2021

Footnotes to Form 4

(1) The shares of the Issuer reported are beneficially owned by: THL Holdco, LLC (“THL Holdco”); Thomas H. Lee Partners, L.P. (“THL”); Thomas H. Lee Advisors, LLC (“THL Advisors”); Thomas H. Lee Equity Fund VI (2019), L.P. (“Fund VI 2019”); THL Fund VI (2019) Coinvestment Partners, L.P. (“Fund VI 2019 Coinvest”); Thomas H. Lee Equity Fund VII, L.P. (“Equity Fund VII”); Thomas H. Lee Parallel Fund VII, L.P.  (“Parallel Fund VII”); Thomas H. Lee Parallel (Cayman) Fund VII, L.P. (“Parallel (Cayman) Fund VII”); THL Executive Fund VII (“Executive Fund VII”); THL Equity Fund VII Investors (inVentiv), L.P. (“Equity Fund VII (inVentiv)”); THL Fund VII Coinvestment Partners, L.P. (“Fund VII Coinvest”); THL Coinvestment Partners, L.P. (“Coinvest Partners”); THL Managers VI, LLC (“THL Managers VI”); THL Managers VII, LLC (“THL Managers VII”) (collectively with their affiliates, the “THL Funds”); Todd M. Abbrecht; and Joshua M. Nelson.

(2) THL Holdco is the managing member of THL Advisors, which in turn is the general partner of THL, which in turn is the sole member of THL Equity Advisors VI (2019), LLC (“Equity Advisors VI (2019)”), the sole member of THL Equity Advisors VII (“Equity Advisors VII”), the general partner of Fund VI 2019 Coinvest, and the general partner of Fund VII Coinvest. Equity Advisors VI (2019) is the general partner of Fund VI 2019. Equity Advisors VII is the general partner of Equity Fund VII, Parallel Fund VII, Parallel (Cayman) Fund VII, Executive Fund VII, and Equity Fund VII (inVentiv).

(3) Each of the Reporting Persons disclaims beneficial ownership of all shares of the Issuer for the purposes of Section 16 or for any other purpose, except to the extent of such Reporting Person’s pecuniary interest therein.

(4) Represents shares directly held by the following entities: 1,558,352 shares by Fund VI 2019, 44,180 shares by Fund VI 2019 Coinvest, 416,114 shares by Equity Fund VII, 328,331 shares by Parallel Fund VII, 440,066 shares by Parallel (Cayman) Fund VII, L.P., 36,474 shares by Executive Fund VII, 63,457 shares by Fund VII Coinvest and 2,714,456 shares by Equity Fund VII (inVentiv).

(5) Represents shares directly held by THL Managers VI following.

(6) Represents shares directly held by THL Managers VII following.

(7) Represents an award of restricted stock units to be settled in shares which vests in full one year from the grant date, or, if earlier, the date of the next subsequent annual meeting following the grant date but only to the extent the director is not re-elected as a non-employee director at such annual meeting, in each case, subject to continued service on the Issuer’s Board of Directors.

(8) Todd M. Abbrecht is a Managing Partner of THL.  Pursuant to the operative agreements among certain of the THL Funds, any securities issued to persons serving as directors of portfolio companies of the THL Funds, such as the Issuer, are to be held for the benefit of the THL Funds.

(9)  Joshua M. Nelson is a Managing Director of THL.  Pursuant to the operative agreements among certain of the THL Funds, any securities issued to persons serving as directors of portfolio companies of the THL Funds, such as the Issuer, are to be held for the benefit of the THL Funds.


 EX-99.2 3 brhc10024660_ex99-2.htm EXHIBIT 99.2
Exhibit 99.2

Joint Filer Information


Name of Joint Filer:
Thomas H. Lee Advisors, LLC
   
Address of Joint Filer:
c/o Thomas H. Lee Partners, L.P.

100 Federal Street, 35th Floor
 
Boston, MA 02110
   
Relationship of Joint Filer to Issuer:
Director
   
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]
   
Date of Earliest Transaction Required to
  
be Reported:
May 12, 2021
   
Designated Filer:
Thomas H. Lee Advisors, LLC

Signature:

THOMAS H. LEE ADVISORS, LLC
By: THL Holdco, LLC, its Managing Member

By:
/s/ Michael McDonnell
  
Name:
Michael McDonnell
  
Title:
Chief Financial Officer, Management Company

May 14, 2021

Exhibit 99.2

Joint Filer Information

Name of Joint Filer:
Thomas H. Lee Equity Fund VI (2019), L.P.
   
Address of Joint Filer:
c/o Thomas H. Lee Partners, L.P.

100 Federal Street, 35th Floor
 
Boston, MA 02110
   
Relationship of Joint Filer to Issuer:
Director
   
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]
   
Date of Earliest Transaction Required to
  
be Reported:
May 12, 2021
   
Designated Filer:
Thomas H. Lee Advisors, LLC

Signature:

THOMAS H. LEE EQUITY FUND VI (2019), L.P.
By: THL Equity Advisors VI (2019), LLC, its General Partner
By: Thomas H. Lee Partners, L.P., its Sole Member
By: Thomas H. Lee Advisors, LLC, its General Partner
By: THL Holdco, LLC, its Managing Member

By:
/s/ Michael McDonnell
  
Name:
Michael McDonnell
  
Title:
Chief Financial Officer, Management Company

May 14, 2021

Exhibit 99.2

Joint Filer Information

Name of Joint Filer:
Thomas H. Lee Partners, L.P.
   
Address of Joint Filer:
100 Federal Street, 35th Floor
 
Boston, MA 02110
   
   
Relationship of Joint Filer to Issuer:
Director
   
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]
   
Date of Earliest Transaction Required to
  
be Reported:
May 12, 2021
   
Designated Filer:
Thomas H. Lee Advisors, LLC

Signature:

THOMAS H. LEE PARTNERS, L.P.
By: Thomas H. Lee Advisors, LLC, its General Partner
By: THL Holdco, LLC, its Managing Member

By:
/s/ Michael McDonnell
  
Name:
Michael McDonnell
  
Title:
Chief Financial Officer, Management Company

May 14, 2021

Exhibit 99.2

Joint Filer Information

Name of Joint Filer:
THL Equity Fund VI (2019) Coinvestment Partners, L.P.
   
Address of Joint Filer:
c/o Thomas H. Lee Partners, L.P.

100 Federal Street, 35th Floor
 
Boston, MA 02110
   
Relationship of Joint Filer to Issuer:
Director
   
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]
   
Date of Earliest Transaction Required to
  
be Reported:
May 12, 2021
   
Designated Filer:
Thomas H. Lee Advisors, LLC

Signature:

THL EQUITY FUND VI (2019) COINVESTMENT PARTNERS, L.P.
By: Thomas H. Lee Partners, L.P., its General Partner
By: Thomas H. Lee Advisors, LLC, its General Partner
By: THL Holdco, LLC, its Managing Member

By:
/s/ Michael McDonnell
  
Name:
Michael McDonnell
  
Title:
Chief Financial Officer, Management Company

May 14, 2021

Exhibit 99.2

Joint Filer Information


Name of Joint Filer:
Thomas H. Lee Equity Fund VII, L.P.
   
Address of Joint Filer:
c/o Thomas H. Lee Partners, L.P.

100 Federal Street, 35th Floor
 
Boston, MA 02110
   
Relationship of Joint Filer to Issuer:
Director
   
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]
   
Date of Earliest Transaction Required to
  
be Reported:
May 12, 2021
   
Designated Filer:
Thomas H. Lee Advisors, LLC

Signature:

THOMAS H. LEE EQUITY FUND VII, L.P.
By: THL Equity Advisors VII, LLC, its General Partner
By: Thomas H. Lee Partners, L.P., its Sole Member
By: Thomas H. Lee Advisors, LLC, its General Partner
By: THL Holdco, LLC, its Managing Member

By:
/s/ Michael McDonnell
  
Name:
Michael McDonnell
  
Title:
Chief Financial Officer, Management Company

May 14, 2021

Exhibit 99.2

Joint Filer Information

Name of Joint Filer:
Thomas H. Lee Parallel Fund VII, L.P.
   
Address of Joint Filer:
c/o Thomas H. Lee Partners, L.P.

100 Federal Street, 35th Floor
 
Boston, MA 02110
   
Relationship of Joint Filer to Issuer:
Director
   
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]
   
Date of Earliest Transaction Required to
  
be Reported:
May 12, 2021
   
Designated Filer:
Thomas H. Lee Advisors, LLC

Signature:

THOMAS H. LEE PARALLEL FUND VII, L.P.
By: THL Equity Advisors VII, LLC, its General Partner
By: Thomas H. Lee Partners, L.P., its Sole Member
By: Thomas H. Lee Advisors, LLC, its General Partner
By: THL Holdco, LLC, its Managing Member


By:
/s/ Michael McDonnell
  
Name:
Michael McDonnell
  
Title:
Chief Financial Officer, Management Company

May 14, 2021

Exhibit 99.2

Joint Filer Information

Name of Joint Filer:
Thomas H. Lee Parallel (Cayman) Fund VII, L.P.
   
Address of Joint Filer:
c/o Thomas H. Lee Partners, L.P.

100 Federal Street, 35th Floor
 
Boston, MA 02110
   
Relationship of Joint Filer to Issuer:
Director
   
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]
   
Date of Earliest Transaction Required to
  
be Reported:
May 12, 2021
   
Designated Filer:
Thomas H. Lee Advisors, LLC

Signature:

THOMAS H. LEE PARALLEL (CAYMAN) FUND VII, L.P.
By: THL Equity Advisors VII, LLC, its General Partner
By: Thomas H. Lee Partners, L.P., its Sole Member
By: Thomas H. Lee Advisors, LLC, its General Partner
By: THL Holdco, LLC, its Managing Member

By:
/s/ Michael McDonnell
  
Name:
Michael McDonnell
  
Title:
Chief Financial Officer, Management Company

May 14, 2021

Exhibit 99.2

Joint Filer Information

Name of Joint Filer:
THL Managers VI, LLC
   
Address of Joint Filer:
c/o Thomas H. Lee Partners, L.P.

100 Federal Street, 35th Floor
 
Boston, MA 02110
   
Relationship of Joint Filer to Issuer:
Director
   
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]
   
Date of Earliest Transaction Required to
  
be Reported:
May 12, 2021
   
Designated Filer:
Thomas H. Lee Advisors, LLC

Signature:

THL MANAGERS VI, LLC

By:
/s/ Michael McDonnell
  
Name:
Michael McDonnell
  
Title:
Chief Financial Officer, Management Company

May 14, 2021

Exhibit 99.2

Joint Filer Information

Name of Joint Filer:
THL Managers VII, LLC
   
Address of Joint Filer:
c/o Thomas H. Lee Partners, L.P.

100 Federal Street, 35th Floor
 
Boston, MA 02110
   
Relationship of Joint Filer to Issuer:
Director
   
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]
   
Date of Earliest Transaction Required to
  
be Reported:
May 12, 2021
   
Designated Filer:
Thomas H. Lee Advisors, LLC

Signature:

THL MANAGERS VII, LLC

By:
/s/ Michael McDonnell
  
Name:
Michael McDonnell
  
Title:
Chief Financial Officer, Management Company

May 14, 2021

Exhibit 99.2

Joint Filer Information

Name of Joint Filer:
THL Holdco, LLC
   
Address of Joint Filer:
c/o Thomas H. Lee Partners, L.P.

100 Federal Street, 35th Floor
 
Boston, MA 02110
   
Relationship of Joint Filer to Issuer:
Director
   
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]
   
Date of Earliest Transaction Required to
  
be Reported:
May 12, 2021
   
Designated Filer:
Thomas H. Lee Advisors, LLC

Signature:

THL Holdco, LLC

By:
/s/ Michael McDonnell
  
Name:
Michael McDonnell
  
Title:
Chief Financial Officer, Management Company

May 14, 2021

Exhibit 99.2

Joint Filer Information

Name of Joint Filer:
THL Fund VII Coinvestment Partners, L.P.
   
Address of Joint Filer:
c/o Thomas H. Lee Partners, L.P.

100 Federal Street, 35th Floor
 
Boston, MA 02110
   
Relationship of Joint Filer to Issuer:
Director
   
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]
   
Date of the Earliest Transaction
  
Required to be Reported (Month/Day/Year):
May 12, 2021
   
Designated Filer:
Thomas H. Lee Advisors, LLC

Signature:

THL FUND VII COINVESTMENT PARTNERS, L.P.
By: Thomas H. Lee Partners, L.P., its General Partner
By: Thomas H. Lee Advisors, LLC, its General Partner
By: THL Holdco, LLC, its Managing Member

By:
/s/ Michael McDonnell
  
Name:
Michael McDonnell
  
Title:
Chief Financial Officer, Management Company

May 14, 2021

Exhibit 99.2

Joint Filer Information

Name of Joint Filer:
THL Executive Fund VII, L.P.
   
Address of Joint Filer:
c/o Thomas H. Lee Partners, L.P.

100 Federal Street, 35th Floor
 
Boston, MA 02110
   
Relationship of Joint Filer to Issuer:
Director
   
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]
   
Date of Earliest Transaction Required to
  
be Reported:
May 12, 2021
   
Designated Filer:
Thomas H. Lee Advisors, LLC

Signature:

THL EXECUTIVE FUND VII, L.P.
By: THL Equity Advisors VII, LLC, its General Partner
By: Thomas H. Lee Partners, L.P., its Sole Member
By: Thomas H. Lee Advisors, LLC, its General Partner
By: THL Holdco, LLC, its Managing Member

By:
/s/ Michael McDonnell
  
Name:
Michael McDonnell
  
Title:
Chief Financial Officer, Management Company

May 14, 2021

Exhibit 99.2

Joint Filer Information

Name of Joint Filer:
THL Equity Fund VII Investors (inVentiv), L.P.
   
Address of Joint Filer:
c/o Thomas H. Lee Partners, L.P.

100 Federal Street, 35th Floor
 
Boston, MA 02110
   
Relationship of Joint Filer to Issuer:
Director
   
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]
   
Date of Earliest Transaction Required to
  
be Reported:
May 12, 2021
   
Designated Filer:
Thomas H. Lee Advisors, LLC

Signature:

THOMAS H. LEE EQUITY FUND VII INVESTORS (INVENTIV), L.P.
By: THL Equity Advisors VII, LLC, its General Partner
By: Thomas H. Lee Partners, L.P., its Sole Member
By: Thomas H. Lee Advisors, LLC, its General Partner
By: THL Holdco, LLC, its Managing Member

By:
/s/ Michael McDonnell
  
Name:
Michael McDonnell
  
Title:
Chief Financial Officer, Management Company

May 14, 2021

 
Exhibit 99.2

Joint Filer Information

Name of Joint Filer:
Todd M. Abbrecht
   
Address of Joint Filer:
c/o Thomas H. Lee Partners, L.P.

100 Federal Street, 35th Floor
 
Boston, MA 02110
   
Relationship of Joint Filer to Issuer:
Director
   
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]
   
Date of Earliest Transaction Required to
  
be Reported:
May 12, 2021
   
Designated Filer:
Thomas H. Lee Advisors, LLC

Signature:

By:
/s/ Todd M. Abbrecht
  
Name:
Todd M. Abbrecht
  

May 14, 2020

Exhibit 99.2

Joint Filer Information

Name of Joint Filer:
Joshua M. Nelson
   
Address of Joint Filer:
c/o Thomas H. Lee Partners, L.P.

100 Federal Street, 35th Floor
 
Boston, MA 02110
   
Relationship of Joint Filer to Issuer:
Director
   
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]
   
Date of Earliest Transaction Required to
  
be Reported:
May 12, 2021
   
Designated Filer:
Thomas H. Lee Advisors, LLC

Signature:

By:
/s/ Joshua M. Nelson
  
Name:
Joshua M. Nelson
  

May 14, 2020